LIN28B and ovarian carcinoma: Recently, it was reported that high expression of the stem cell-associated gene LIN28B is related to a poor outcome, including higher mortality and relapse in patients with ovarian cancer, suggesting that this cancer stem cell-associated marker may be a therapeutic target in epithelial ovarian cancer [58].